Orthodontics practices sell for 2.5x to 5.0x SDE or 4.0x to 8.0x EBITDA, measuring earnings before interest, taxes, depreciation, and amortization—the annual operating profit from treatment fees across braces, clear aligners, and ancillary services. Practices with 150+ annual case starts, balanced treatment mix, strong pending revenue, and associate coverage consistently achieve the upper range. The valuation spread reflects production scale, revenue quality, and operational structure that buyers evaluate when pricing orthodontics acquisitions.

Annual case start volume and growth momentum create the largest valuation difference because case volume translates directly to revenue scalability and production predictability. Practices with 150-300 annual case starts demonstrate sufficient patient production to support associate orthodontist productivity and expansion readiness. Case starts represent new patient commitments to multi-year treatment plans generating recurring monthly revenue through completion. Declining case starts signal market weakness or practice operational issues despite current patient census because treatment completions eventually reduce active patients. Buyers model three to five-year case start projections to assess revenue trajectory, evaluating whether production represents organic growth or seasonal variation. Consistent case starts above 200 indicate referral networks and patient acquisition systems that sustain the practice through market cycles and support multi-clinician operations.

Average case fee positioning relative to geographic market determines overall practice revenue and margin profile. Markets vary significantly in treatment fee levels based on demographic affluence, insurance plan reimbursement rates, competitive practice density, and cost of living. Cash-pay dominated markets in affluent regions support higher average case fees of $6,500-$9,000 for comprehensive treatment. Insurance-dependent markets typically command $4,500-$6,500 average fees. Practices with above-market fee positioning typically serve affluent demographics or demonstrate superior outcomes justifying premium pricing. Shifting toward higher-fee clear aligner cases improves overall practice economics compared to lower-fee traditional braces. Buyers evaluate fee positioning within market context because it indicates practice quality reputation and demographic capture, similar to pricing analysis in dental practice valuation methodology.

Treatment mix diversification across braces and clear aligners captures patients across demographic preferences and reduces single-product dependency. Clear aligner market growth of 15-20% annually reflects patient esthetic preferences, particularly among adults and affluent teenagers willing to pay premium fees. Practices with 50-60% braces and 40-50% aligners demonstrate balanced product offerings. Braces-only practices miss aligner revenue from esthetic and adult treatment seekers. Clear aligner production requires digital scanning infrastructure, specialized training, and treatment planning systems that create differentiation. Buyers value treatment mix diversity because it demonstrates market adaptability and insulates revenue from product category disruption, comparable to service diversification analyzed in medical practice valuation frameworks.

Associate orthodontist capacity and engagement determine practice scalability and owner-independent operations. Single-doctor practices cap revenue at individual clinician productivity of 800-1,200 patient visits annually. Adding associates expands capacity 50-80%, enabling the same facility to serve significantly more patients. Associate compensation of $150K-$220K represents modest cost relative to $300K-$500K additional annual revenue provided. Owner-dependent practices where the founder handles 80%+ of treatment create dependency reducing post-acquisition earnings. Practices with engaged associates demonstrate operational depth enabling continued performance post-acquisition. Buyers heavily weight associate structure because it determines whether they acquire scalable practice operations or require seller ongoing involvement.

Pending treatment revenue balance represents contracted future income from active patients mid-treatment and creates earnings visibility. A practice with $300K monthly revenue and $900K pending balance represents three months of contracted revenue already committed. Pending revenue stability insulates the practice from month-to-month patient acquisition variation. Practices with pending balances exceeding 90 days of monthly revenue demonstrate established patient bases with strong case completion rates. Low pending revenue relative to current revenue indicates high patient turnover or case dropout creating instability. Buyers evaluate pending revenue quality by analyzing patient demographics, treatment stage distribution, and payment patterns. Increasing pending revenue demonstrates growing patient production and future revenue growth.

Multi-location expansion potential through satellite offices or partnership arrangements creates enterprise value beyond single-location practice economics. Successful practices with systemized patient acquisition, strong clinical processes, and qualified associates can expand to two or three locations maintaining consistent outcomes. Satellite offices in adjacent markets leverage practice brand and referral relationships for faster productivity ramp. Partnership arrangements with general dentistry practices create referral relationships and revenue opportunities. Practices demonstrating multi-location success or clear expansion playbooks attract DSO platforms and PE firms building consolidated networks. Buyers evaluate geographic expansion readiness because it indicates growth potential, comparable to multi-location evaluation frameworks in medical practice acquisition analysis.

Adjusted SDE normalizes owner compensation to market rates, associates' productivity, and discretionary practice expenses. A practice generating $1.2M annual revenue with $350K adjusted SDE at 3.5x values at $1.225M. A comparable practice with 200+ annual case starts, balanced treatment mix, and strong pending revenue might command 4.5x, or $1.575M—the $350K premium reflects production scale and revenue predictability. Real estate and equipment represent additional value if owned.

The buyer landscape includes DSO platforms paying 4.5x-5.0x SDE for multi-clinician practices with strong pending revenue, private equity firms at 4.0x-4.5x building consolidated networks, independent orthodontists at 3.0x-4.0x seeking acquisitions to add case volume, and smaller operators at 2.5x-3.5x acquiring single-clinician practices. DSO platforms pay top multiples because acquired practices integrate into multi-location networks benefiting from centralized operations, administrative consolidation, and cross-practice referral relationships. Related industries that follow similar consolidation dynamics include Oral Surgery Practice.